← Leaderboards
Craig Stanford Broberg
Oregon Health & Science University
$1,394,346
Attributed
$1,394,346
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.6K · FY2009–15$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,394,346 · 2
By mechanism
R34$739,776 · 1
K23$654,570 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Sandra Rugonyi$6,036,358
- Jorge Enrique Tolosa$1,418,308
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPrevalenceMagnetic Resonance ImagingFunctional DisorderEfracExerciseFibrosisCongenital Heart DisorderDevelopment PlansArchitectureAldosteroneDiffuseEisenmenger ComplexEnsureCollagenCollagen Type IiiCardiovascular SystemCollagen Type IAdultBrain Natriuretic PeptideCardiacCardiologyCardiovascular PhysiologyClinical Research
Grant awards (8)
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study$265,809
R34 · FY2015 · HL · contact PI
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study$193,475
R34 · FY2014 · HL · contact PI
Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study$280,492
R34 · FY2013 · HL · contact PI
Heart Failure in Congenital Heart Disease: The role of Myocardial Fibrosis$129,090
K23 · FY2013 · HL · contact PI
Heart Failure in Congenital Heart Disease: The role of Myocardial Fibrosis$131,730
K23 · FY2012 · HL · contact PI
Heart Failure in Congenital Heart Disease: The role of Myocardial Fibrosis$131,730
K23 · FY2011 · HL · contact PI
Heart Failure in Congenital Heart Disease: The role of Myocardial Fibrosis$131,730
K23 · FY2010 · HL · contact PI
Heart Failure in Congenital Heart Disease: The role of Myocardial Fibrosis$130,290
K23 · FY2009 · HL · contact PI